Huntington's disease: new hope for therapeutics
- 1 November 2001
- journal article
- review article
- Published by Elsevier in Trends in Neurosciences
- Vol. 24 (11) , S32-S38
- https://doi.org/10.1016/s0166-2236(00)01997-4
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disordersAnnals of Neurology, 2001
- Extended polyglutamine selectively interacts with caspase-8 and -10 in nuclear aggregatesCell Death & Differentiation, 2001
- Mutant Huntingtin Enhances Excitotoxic Cell DeathMolecular and Cellular Neuroscience, 2001
- Neurodegeneration: diseases of the cytoskeleton?Cell Death & Differentiation, 2000
- Caspase Inhibition Increases Embryonic Striatal Graft SurvivalExperimental Neurology, 2000
- Inhibiting Caspase Cleavage of Huntingtin Reduces Toxicity and Aggregate Formation in Neuronal and Nonneuronal CellsJournal of Biological Chemistry, 2000
- Mammalian Caspases: Structure, Activation, Substrates, and Functions During ApoptosisAnnual Review of Biochemistry, 1999
- Antisense Gene Therapy for Neurodegenerative Disease?Experimental Neurology, 1997
- Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutationNature Genetics, 1997
- Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic MiceCell, 1996